Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease lymphopenia
Phenotype C0026769|multiple sclerosis
Sentences 1
PubMedID- 25361781 Objective: to assess whether pretreatment-lymphocyte counts, treatment before fingolimod, age, sex, or body mass index (bmi) affects the risk of fingolimod-induced lymphopenia in patients with relapsing-remitting multiple sclerosis (rrms).

Page: 1